151 related articles for article (PubMed ID: 38348038)
1. Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma.
Zhao Y; Yang T; Ouyang Y; Rao W; Liu K; Zheng J; Lv F; Shi Y; Wang F; Liu D; Qiao L; Xia Z; Zhang Y; Chen D; Wang W
Front Immunol; 2024; 15():1339213. PubMed ID: 38348038
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma.
Mizukoshi E; Yamashita T; Arai K; Sunagozaka H; Ueda T; Arihara F; Kagaya T; Yamashita T; Fushimi K; Kaneko S
Hepatology; 2013 Apr; 57(4):1448-57. PubMed ID: 23174905
[TBL] [Abstract][Full Text] [Related]
3. Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response.
Qi X; Yang M; Ma L; Sauer M; Avella D; Kaifi JT; Bryan J; Cheng K; Staveley-O'Carroll KF; Kimchi ET; Li G
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115942
[TBL] [Abstract][Full Text] [Related]
4. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation.
Shi ZR; Duan YX; Cui F; Wu ZJ; Li MP; Song PP; Peng QL; Ye WT; Yin KL; Kang MQ; Yu YX; Yang J; Tang W; Liao R
J Exp Clin Cancer Res; 2023 May; 42(1):133. PubMed ID: 37231509
[TBL] [Abstract][Full Text] [Related]
5. The current role of radiofrequency ablation in the treatment of intrahepatic recurrent hepatocellular carcinoma.
Fu R; Ling W
J Surg Oncol; 2023 Dec; 128(8):1340-1346. PubMed ID: 37753714
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation in the treatment of hepatocellular carcinoma.
Deng Q; He M; Fu C; Feng K; Ma K; Zhang L
Int J Hyperthermia; 2022; 39(1):1052-1063. PubMed ID: 35944905
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.
Zerbini A; Pilli M; Penna A; Pelosi G; Schianchi C; Molinari A; Schivazappa S; Zibera C; Fagnoni FF; Ferrari C; Missale G
Cancer Res; 2006 Jan; 66(2):1139-46. PubMed ID: 16424051
[TBL] [Abstract][Full Text] [Related]
8. Peripheral T-cell subsets in radiofrequency ablation for tumors from different origins.
Jin Y; Zhao Q; Fan C; Song X; Teng C; Lv Y; Jiang Q; Huang D; Li L; Shen W; Xin T
Asian J Surg; 2024 Mar; 47(3):1378-1382. PubMed ID: 38160147
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis.
Wang X; Liu G; Chen S; Bi H; Xia F; Feng K; Ma K; Ni B
Int J Hyperthermia; 2021 Oct; 38(1):1519-1528. PubMed ID: 34702122
[TBL] [Abstract][Full Text] [Related]
12. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
[TBL] [Abstract][Full Text] [Related]
13. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
[TBL] [Abstract][Full Text] [Related]
14. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
[TBL] [Abstract][Full Text] [Related]
15. Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases.
Hansler J; Wissniowski TT; Schuppan D; Witte A; Bernatik T; Hahn EG; Strobel D
World J Gastroenterol; 2006 Jun; 12(23):3716-21. PubMed ID: 16773688
[TBL] [Abstract][Full Text] [Related]
16. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
Guan HT; Wang J; Yang M; Song L; Tong XQ; Zou YH
Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
[TBL] [Abstract][Full Text] [Related]
17. Effect of RFA and TACE combined with postoperative cytokine-induced killer cell immunotherapy in primary hepatocellular carcinoma.
Ji Q; Fu Y; Zhu X; Wang L; Ling C
J BUON; 2021; 26(1):235-242. PubMed ID: 33721457
[TBL] [Abstract][Full Text] [Related]
18. Alterations in serum metabolic profiles of early-stage hepatocellular carcinoma patients after radiofrequency ablation therapy.
Zhang F; Wu J; Zhang L; Zhang J; Yang R
J Pharm Biomed Anal; 2024 Jun; 243():116073. PubMed ID: 38484637
[TBL] [Abstract][Full Text] [Related]
19. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
[TBL] [Abstract][Full Text] [Related]
20. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]